Claybrook Capital’s Dentsply Sirona XRAY Stock Holding History

Claybrook Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,008	Closed	-$38K	–	708
2018 Q4	$38K	Buy	+1,008	New	+$36.7K	0.01%	287

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Claybrook Capital's XRAY Position: Q1 2019 in Review

Claybrook Capital sold out of Dentsply Sirona (XRAY) in Q1 2019, closing a stake of 1,008 shares — an estimated $38K sold.

Claybrook Capital first reported a position in XRAY in Q4 2018 and held it in 1 quarter. The position peaked at $38K in Q4 2018. 530 funds tracked by Wall St. Rank hold XRAY as of Q1 2019.

Claybrook Capital reported no remaining Dentsply Sirona position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 1,008 Dentsply Sirona shares in Q1 2019, an estimated $38K.
Claybrook Capital first reported a position in Dentsply Sirona in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Dentsply Sirona position peaked at $38K in Q4 2018.
530 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.